DA Lomas

887 total citations
28 papers, 629 citations indexed

About

DA Lomas is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, DA Lomas has authored 28 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 7 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in DA Lomas's work include Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Protease and Inhibitor Mechanisms (7 papers) and Peptidase Inhibition and Analysis (4 papers). DA Lomas is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Protease and Inhibitor Mechanisms (7 papers) and Peptidase Inhibition and Analysis (4 papers). DA Lomas collaborates with scholars based in United Kingdom, United States and Denmark. DA Lomas's co-authors include Ravi Mahadeva, P Bakke, Amund Gulsvik, Michael J. Davies, Guohua Zhu, Edward Silverman, Robert A. Stockley, Wayne H. Anderson, Sreekumar Pillai and Srinivas Ghatta and has published in prestigious journals such as Human Molecular Genetics, British Journal of Cancer and European Respiratory Journal.

In The Last Decade

DA Lomas

28 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
DA Lomas United Kingdom 14 313 167 151 130 79 28 629
Xiaoxi Chen China 15 225 0.7× 269 1.6× 165 1.1× 221 1.7× 184 2.3× 48 784
Carla Irani Lebanon 11 144 0.5× 194 1.2× 256 1.7× 53 0.4× 60 0.8× 37 669
F Taki Japan 11 159 0.5× 88 0.5× 120 0.8× 50 0.4× 35 0.4× 17 374
Kuniko Masuyama Japan 10 223 0.7× 112 0.7× 167 1.1× 54 0.4× 39 0.5× 12 466
Adela Serrano Spain 13 435 1.4× 262 1.6× 199 1.3× 54 0.4× 68 0.9× 18 765
Nikica Miše Germany 8 247 0.8× 231 1.4× 82 0.5× 74 0.6× 107 1.4× 9 550
Marco Failla Italy 10 360 1.2× 240 1.4× 271 1.8× 39 0.3× 60 0.8× 12 763
Hongjie Guo China 13 105 0.3× 311 1.9× 27 0.2× 113 0.9× 200 2.5× 46 731
V. Znojil Czechia 17 169 0.5× 143 0.9× 234 1.5× 79 0.6× 71 0.9× 50 766
Lidia Michalec United States 12 122 0.4× 149 0.9× 305 2.0× 43 0.3× 41 0.5× 18 803

Countries citing papers authored by DA Lomas

Since Specialization
Citations

This map shows the geographic impact of DA Lomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DA Lomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DA Lomas more than expected).

Fields of papers citing papers by DA Lomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DA Lomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DA Lomas. The network helps show where DA Lomas may publish in the future.

Co-authorship network of co-authors of DA Lomas

This figure shows the co-authorship network connecting the top 25 collaborators of DA Lomas. A scholar is included among the top collaborators of DA Lomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DA Lomas. DA Lomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rabinovich, Roberto, Bruce E. Miller, Krzysztof Wróbel, et al.. (2014). S51 Circulating Desmosine Relates To Cardiovascular Comorbidity, Coronary Artery Calcification Score (cacs), Systemic Inflammation And Mortality In Patients With Copd. Thorax. 69(Suppl 2). A28–A29. 1 indexed citations
3.
Briggs, Andrew, DA Lomas, Maureen Rutten‐van Mölken, et al.. (2013). Developing A New Model Of Copd: From Conceptualisation To Implementation To Validation. Value in Health. 16(3). A234–A235. 2 indexed citations
4.
Dalton, Lucy E., Hugh J. Clarke, Jenny Knight, et al.. (2013). The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma. British Journal of Cancer. 108(6). 1340–1347. 53 indexed citations
5.
Siedliński, Mateusz, Minyoung Cho, P Bakke, et al.. (2011). Genome-wide association study of smoking behaviours in patients with COPD. Thorax. 66(10). 894–902. 86 indexed citations
6.
Davies, Nathan, et al.. (2011). PREVALENCE AND RISK FACTORS FOR LIVER INVOLVEMENT IN INDIVIDUALS WITH PIZ-RELATED LUNG DISEASE. UCL Discovery (University College London). 6 indexed citations
7.
Washko, George R., Augusto A. Litonjua, David Sparrow, et al.. (2010). Polymorphisms in the Superoxide Dismutase-3 Gene Are Associated with Emphysema in COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 7(4). 262–268. 42 indexed citations
8.
Zhu, Guohua, Àlvar Agustí, Amund Gulsvik, et al.. (2009). CTLA4gene polymorphisms are associated with chronic bronchitis. European Respiratory Journal. 34(3). 598–604. 22 indexed citations
9.
Zhu, Guohua, Amund Gulsvik, P Bakke, et al.. (2009). Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Human Molecular Genetics. 18(11). 2053–2062. 88 indexed citations
10.
Davies, Michael J. & DA Lomas. (2008). The molecular aetiology of the serpinopathies. The International Journal of Biochemistry & Cell Biology. 40(6-7). 1273–1286. 29 indexed citations
11.
Lomas, DA. (2006). The selective advantage of alpha(1)-antitrypsin deficiency. UCL Discovery (University College London). 5 indexed citations
12.
Welch, AA, et al.. (2003). Are smokers with low plasma vitamin C levels at particular risk of COPD?. UCL Discovery (University College London). 1 indexed citations
13.
Dafforn, Timothy R., et al.. (2000). Pathogenic alpha(1)-antitrypsin polymers are formed by reactive loop-beta-sheet A linkage. UCL Discovery (University College London). 1 indexed citations
14.
Lomas, DA, et al.. (2000). Alpha-1-Antitrypsin Deficiency, the Serpinopathies and Conformational Disease. Journal of the Royal College of Physicians of London. 34(3). 295–300. 16 indexed citations
15.
Lomas, DA, et al.. (1999). The interaction of M, S, Z, latent and cleaved plasma alpha-1-antitrypsin with human neutrophil defensin-1.. UCL Discovery (University College London). 1 indexed citations
16.
Mahadeva, Ravi, Linda Sharples, D. B. Whitehouse, et al.. (1999). Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease. Clinical & Experimental Immunology. 117(3). 561–567. 49 indexed citations
17.
Mahadeva, Ravi, D. B. Whitehouse, R. Ross‐Russell, et al.. (1998). Alpha1-antitrypsin deficiency alleles and the Taq-I G-->A allele in cystic fibrosis lung disease. European Respiratory Journal. 11(4). 873–879. 46 indexed citations
18.
Mahadeva, Ravi & DA Lomas. (1998). Genetics and respiratory disease bullet  2: Alpha1-antitrypsin deficiency, cirrhosis and emphysema. Thorax. 53(6). 501–505. 87 indexed citations
19.
Lomas, DA, et al.. (1997). Commercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent component. European Respiratory Journal. 10(3). 672–675. 16 indexed citations
20.
Lomas, DA, et al.. (1994). The effect of the Z mutation on the ability of α1-antirtrypsin to prevent neutrophil mediated tissue damage. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1227(3). 155–160. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoxi Chen Breakdown of academic impact, for papers by Carla Irani Breakdown of academic impact, for papers by F Taki Breakdown of academic impact, for papers by Kuniko Masuyama Breakdown of academic impact, for papers by Adela Serrano Breakdown of academic impact, for papers by Nikica Miše Breakdown of academic impact, for papers by Marco Failla Breakdown of academic impact, for papers by Hongjie Guo Breakdown of academic impact, for papers by V. Znojil Breakdown of academic impact, for papers by Lidia Michalec
Rankless by CCL
2026